Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51,855 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SARS-CoV-2 mRNA Vaccine Elicits Sustained T Cell Responses Against the Omicron Variant in Adolescents.
Choi S, Kim SH, Han MS, Yoon Y, Kim YK, Cho HK, Yun KW, Song SH, Ahn B, Kim YK, Choi SH, Choe YJ, Lim H, Choi EB, Kim K, Hyeon S, Lim HJ, Kim BC, Lee YK, Choi EH, Shin EC, Lee H. Choi S, et al. Among authors: kim bc, kim yk, kim sh, kim k. Immune Netw. 2023 Aug 11;23(4):e33. doi: 10.4110/in.2023.23.e33. eCollection 2023 Aug. Immune Netw. 2023. PMID: 37670807 Free PMC article.
Loss of Neutralizing Activity of Tixagevimab/Cilgavimab (Evusheld™) Against Omicron BN.1, a Dominant Circulating Strain Following BA.5 During the Seventh Domestic Outbreak in Korea in Early 2023.
Yang J, Hyeon S, Baek JY, Kang MS, Lee KY, Lee YH, Huh K, Cho SY, Kang CI, Chung DR, Peck KR, Won G, Lee HW, Kim K, Hwang I, Lee SY, Kim BC, Lee YK, Ko JH. Yang J, et al. Among authors: kim bc, kim k. J Korean Med Sci. 2023 Jul 10;38(27):e205. doi: 10.3346/jkms.2023.38.e205. J Korean Med Sci. 2023. PMID: 37431539 Free PMC article.
Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules.
Choi JY, Lee YJ, Ko JH, Kim SH, Kim HJ, Lee HW, Jeong H, Kim TY, Jang YG, Hong HJ, Kim MS, Lee SE, Kim YG, Chung EJ, Lim H, Jang S, Kim K, Kim SS, Ahn JY, Choi JY, Kim YC, Park YS, Peck KR, Kim B. Choi JY, et al. Among authors: kim ss, kim hj, kim b, kim sh, kim ty, kim ms, kim yc, kim yg, kim k. Front Cell Infect Microbiol. 2022 Jul 11;12:948014. doi: 10.3389/fcimb.2022.948014. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35899050 Free PMC article.
Neutralizing activity against Omicron BA.5 after tixagevimab/cilgavimab administration comparable to those after Omicron BA.1/BA.2 breakthrough infections.
Yang J, Won G, Baek JY, Lee YH, Kim H, Huh K, Cho SY, Kang CI, Chung DR, Peck KR, Lee KW, Park JB, Yoon SE, Kim SJ, Kim WS, Yim MS, Kim K, Hyeon S, Kim BC, Lee YK, Ko JH. Yang J, et al. Among authors: kim h, kim bc, kim sj, kim ws, kim k. Front Immunol. 2023 Mar 2;14:1139980. doi: 10.3389/fimmu.2023.1139980. eCollection 2023. Front Immunol. 2023. PMID: 36936968 Free PMC article.
Conversion surgery for initially unresectable locally advanced biliary tract cancer: A multicenter collaborative study conducted in Japan and Korea.
Yabushita Y, Park JS, Yoon YS, Ohtsuka M, Kwon W, Choi GH, Imamura M, Matsumoto I, Mizuno S, Matsuyama R, Sakata J, Hayashi H, Takeda Y, Katagiri S, Sugawara T, Kobayashi S, Kawasaki Y, Nagano H, Murase K, Kim HS, Nah YW, Jang JY, Yamaue H, Yoon DS, Yamamoto M, Choi D, Nakamura M, Kim KH, Endo I. Yabushita Y, et al. Among authors: kim kh. J Hepatobiliary Pancreat Sci. 2024 May 31. doi: 10.1002/jhbp.1437. Online ahead of print. J Hepatobiliary Pancreat Sci. 2024. PMID: 38822227
51,855 results
You have reached the last available page of results. Please see the User Guide for more information.